MedPath

Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway in Patients After Knee Arthroplasty

Not Applicable
Completed
Conditions
Arthroplasty, Replacement, Knee
Registration Number
NCT02962453
Lead Sponsor
Ulsan University Hospital
Brief Summary

The aim of this study is to determine the clinical efficacy of gait rehabilitation robot through cortico-spinal-muscular pathway activation of the muscles remotely located from the end-effecter in patients after total knee arthroplasty.

Detailed Description

pre-interventional evaluation; within 1 day of intervention start primary end point; 3 days after intervention start secondary end point; 5 days after intervention start

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients after Unilateral Total Knee Arthroplasty
Exclusion Criteria
  • brain disease, spinal cord injury, peripheral neuropathy, myopathy
  • Inability to ambulate fully due to muscukoskeletal disorders
  • MMSE<23
  • history of arthroplasty surgery on either of legs
  • Cardiac pacemaker
  • Refusal of participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change of Isometric muscle strength0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

peak torque (Nm/㎡), Maximal ratio of torque development (RTD) (degree/sec)

Secondary Outcome Measures
NameTimeMethod
Change of Spinal Motor-neuron Excitability0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

Peak to peak Max. H-reflex (mV/mV), Peak to peak Max. H-wave/Max. M-reflex (mV/mV\*㎡)

Change of Cross-sectional area and volume of thigh muscle0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

Cross-sectional area (c㎡) and and volume (cm3)

Change of Cortico-motor Excitability0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

maximum \& mean amplitude of peak to peak MEP (mV and mV), amplitude of peak to peak MEP/maximum M-wave (mV/mV)

Change of Muscle work0 day( within 6 hours before the treatment start) and 5 day(within 6 hours after treatment stop)

peak and mean amplitude of CMAP (mV and mV) and mean area \& total area of CMAP (c㎡/sec and c㎡/sec)

Trial Locations

Locations (1)

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Ulsan University Hospital
🇰🇷Ulsan, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.